From Surf Wiki (app.surf) — the open knowledge base
Enoyl-acyl carrier protein reductase
InterPro Family
InterPro Family
| Field | Value |
|---|---|
| Name | Enoyl-acyl carrier protein reductase |
| EC_number | 1.3.1.9 |
| CAS_number | 37251-08-4 |
| GO_code | 0016631 |
| image | 5cp8.jpg |
| width | 270 |
| caption | Enoyl-[acyl-carrier-protein] reductase [NADH] tetramer, Mycobacterium tuberculosis |
Enoyl-acyl carrier protein reductase (ENR or FabI) (), is a key enzyme of the type II fatty acid synthesis (FAS) system. ENR is an attractive target for narrow-spectrum antibacterial drug discovery because of its essential role in metabolism and its sequence conservation across many bacterial species. In addition, the bacterial ENR sequence and structural organization are distinctly different from those of mammalian fatty acid biosynthesis enzymes.
:[[Image:FattyAcid-MB-Reduction2.svg|400px]]
At lower concentrations, Triclosan and Triclocarban provide a bacteriostatic effect by binding to ENR. Atromentin and leucomelone possess antibacterial activity, inhibiting the enzyme in the bacteria Streptococcus pneumoniae.
References
References
- (August 2004). "Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl-carrier protein) reductase from Plasmodium falciparum". The Biochemical Journal.
- (May 2004). "Identification and characterization of inhibitors of bacterial enoyl-acyl carrier protein reductase". Antimicrobial Agents and Chemotherapy.
- (December 2006). "Atromentin and leucomelone, the first inhibitors specific to enoyl-ACP reductase (FabK) of Streptococcus pneumoniae". The Journal of Antibiotics.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Enoyl-acyl carrier protein reductase — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report